Skip to contentP
Phio Pharmaceuticals Corp.
P
PHIOPhio Pharmaceuticals Corp. Q2 2015 · 10-Q
Revenue$0.00$0.00derivedno prior Q2 2014 on file Net Income-$2.17M-$2.17MN/M vs Q2 2014 EPS Diluted-$0.50-$0.50N/M vs Q2 2014 Operating Income-$2,165,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,800,000N/M Free Cash Flowderived-$1,831,000— ended Jun 30, 2015 · filed Aug 12, 2015 · 43 d after period end